|
||||||||
In this issue:
|
||||||||
![]() |
Should low grade prostate 'cancer' be reclassified?20 Feb 2023
|
|||||||
![]() |
Too many prostate patients still not involved in treatment decisions9 Feb 2023
|
|||||||
![]() |
Prostate patient involvement in decisions brings 'measurable benefit'1 Feb 2023
|
|||||||
Prostate research and treatments
EAU podcast - discussion on active surveillance for prostate cancer |
||||||||
Combining PSA with epigenetic test could reduce biopsies |
||||||||
What is the PROBASE trial? |
||||||||
Denial in prostate cancer patients |
||||||||
Europa Uomo News
EUPROMS 2.0 one-year follow-up questionnaire |
||||||||
Europa Uomo's assignments at EAU23 |
||||||||
Lithuania launches patient mentorship programme |
||||||||
Europa Uomo's sixth webinar on active surveillance |
||||||||
Results of EUPROMS 2.0 |
||||||||
FREE SUBSCRIPTION TO EUROPA UOMO MONTHLY UPDATE All previous issues are available on website: www.europa-uomo.org/newsletters/ |
||||||||
UPDATE is published by the Board of Europa Uomo for its member organisations. Editorial and production: Anja Vancauwenbergh. |